Attached files
| file | filename |
|---|---|
| S-1MEF - S-1MEF - Karyopharm Therapeutics Inc. | a2217286zs-1mef.htm |
| EX-5.1 - EX-5.1 - Karyopharm Therapeutics Inc. | a2217286zex-5_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-1 of Karyopharm Therapeutics Inc. filed pursuant to Rule 462(b) of the Securities Act of 1933, as amended, of our report dated September 4, 2013, except for Note 11, as to which the date is October 25, 2013, relating to our audits of the consolidated financial statements, appearing in the Prospectus, which is a part of the Registration Statement (Form S-1 No. 333-191584) declared effective on November 5, 2013.
We also consent to the reference to our firm under the caption "Experts" in such Prospectus.
/s/ McGladrey LLP
Boston,
Massachusetts
November 5, 2013